irinotecan has been researched along with transferrin in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Furuse, J; Hosokawa, Y; Iwamoto, N; Kase, Y; Kitagawa, N; Miyazawa, T; Motoori, S; Saisho, H | 1 |
| Bi, Y; Lee, RJ; Li, C; Li, L; Sun, Y; Teng, L; Wang, M; Wang, X; Xie, J | 1 |
2 other study(ies) available for irinotecan and transferrin
| Article | Year |
|---|---|
[Two cases of colorectal cancer presenting with periodic, transient elevation of serum iron after chemotherapy including irinotecan].
Topics: Aged; Antineoplastic Agents, Phytogenic; Camptothecin; Colorectal Neoplasms; Female; Humans; Irinotecan; Iron; Transferrin | 2010 |
Liposomal codelivery of an SN38 prodrug and a survivin siRNA for tumor therapy.
Topics: Animals; Apoptosis; Biological Transport; Camptothecin; Cell Line, Tumor; Cell Survival; Drug Delivery Systems; Endocytosis; Female; Gene Silencing; Gene Transfer Techniques; HeLa Cells; Humans; Inhibitor of Apoptosis Proteins; Irinotecan; Liposomes; Mice, Nude; Neoplasms; Particle Size; Prodrugs; RNA, Small Interfering; Survivin; Tissue Distribution; Transferrin | 2018 |